Ps1375 updated safety and efficacy from a phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myelomaL. Costa, E. Stadtmauer, F. Davies, G. Monohan, T. Kovacsovics, N. Burwick, A. Jakubowiak,J. Kaufman, W.-J. Hong, K. Freise,J. Ross,J. Pesko, W. Munasinghe, S. Gudipati, S. Mudd,O. Bueno,S. KumarHemaSphere（2019）引用 2|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
